Intensive chemotherapy of poor prognosis myelodysplastic syndromes (MDS) and acute myeloid leukemia following MDS with idarubicin and cytarabine-Reference-Cited by-同舟云学术

Intensive chemotherapy of poor prognosis myelodysplastic syndromes (MDS) and acute myeloid leukemia following MDS with idarubicin and cytarabine

Published:1997-02 Issue:2 Volume:21 Page:133-138
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Ruutu Tapani,Hänninen Auli,Järventie Greta,Koistinen Pirjo,Koivunen Elli,Kätkä Kalevi,Nousiainen Tapio,Oksanen Kalevi,Pelliniemi Tarja-Terttu,Remes Kari,Timonen Timo,Volin Liisa,Elonen Erkki

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference27 articles.

1. Intensive chemotherapy in myelodysplastic syndromes;Hamblin;Blood Rev.,1992

2. Prognostic factors in myelodysplastic syndromes;Sanz;Leukemia Res.,1992

3. The role of intensive chemotherapy in myelodysplastic syndromes;Fenaux;Leukemia and Lymphoma,1992

4. Intensive chemotherapy and bone marrow transplantation for myelodysplastic syndromes;Löffler;Hematol Oncol. Clin. N. Am.,1992

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Energy metabolism and drug response in myeloid leukaemic stem cells;British Journal of Haematology;2019-06-24

2. Characterization and targeting of malignant stem cells in patients with advanced myelodysplastic syndromes;Nature Communications;2018-09-12

3. Stopping Higher-Risk Myelodysplastic Syndrome in Its Tracks;Current Hematologic Malignancy Reports;2014-09-11

4. Survival improvement of poor-prognosis AML/MDS patients by maintenance treatment with low-dose chemotherapy and differentiating agents;Annals of Hematology;2014-04-06

5. Myelodysplastische Syndrome;Der Internist;2013-05-10